Location History:
- Germantown, TN (US) (2012)
- Scottsdale, AZ (US) (2014)
Company Filing History:
1 out of 764 
1 out of 832,843 Years Active: 2012-2014
Title: Innovations by Inventor Kui Zeng
Introduction
Kui Zeng is an accomplished inventor based in Scottsdale, AZ (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of anti-inflammatory compounds. With a total of 2 patents, his work focuses on innovative solutions for health-related challenges.
Latest Patents
Zeng's latest patents include groundbreaking research on anti-inflammatory quinic acid derivatives for radioprotection and radiomitigation. These patents disclose methods for using analogs of quinic acids or shikimic acids to protect against the harmful effects of radiation. This protection can be administered before or after radiation exposure, making it valuable for treating both humans and animals at risk of radiation sickness. Another notable patent involves anti-inflammatory quinic acid derivatives suitable for oral administration. These compounds demonstrate significant efficacy in inhibiting NF-kB and leukocyte adhesion, which are critical factors in inflammatory diseases.
Career Highlights
Throughout his career, Kui Zeng has worked with various organizations, including the University of Tennessee Research Foundation. His research has contributed to advancements in the understanding and treatment of inflammatory conditions and radiation exposure.
Collaborations
Zeng has collaborated with notable individuals in his field, including Charles Ryan Yates and Duane Douglas Miller. These partnerships have enhanced the impact of his research and innovations.
Conclusion
Kui Zeng's contributions to medicinal chemistry through his patents and collaborations highlight his commitment to addressing significant health challenges. His innovative work continues to pave the way for advancements in treatment options for radiation exposure and inflammatory diseases.